Advertisement

U.S. markets closed

S&P Futures
4,218.75
+8.75(+0.21%)
Dow Futures
33,331.00
+71.00(+0.21%)
Nasdaq Futures
13,432.75
+40.75(+0.30%)
Russell 2000 Futures
1,973.50
+4.00(+0.20%)
Crude Oil
91.60
-0.33(-0.36%)
Gold
1,806.10
-7.60(-0.42%)

Advertisement

Actinium Pharmaceuticals, Inc. (ATNM)

NYSE American - NYSE American Delayed Price. Currency in USD

Add to watchlist

Visitors trend2W10W9M

5.65

+0.24

(+4.44%)

At close: 04:00PM EDT

5.57

-0.08

(-1.42%)

After hours:

07:56PM EDT

Advertisement

Full screen

Trade prices are not sourced from all markets

Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies

Chart Events

Bearishpattern detected

Fast Stochastic

View all chart patterns

Performance Outlook

Previous Close	5.41
Open	5.47
Bid	5.64 x 2200
Ask	5.93 x 800
Day's Range	5.42 - 5.71
52 Week Range	4.41 - 10.30
Volume	65,425
Avg. Volume	153,066

Market Cap	134.382M
Beta (5Y Monthly)	0.40
PE Ratio (TTM)	N/A
EPS (TTM)	-1.14
Earnings Date	Jun 29, 2020
Forward Dividend & Yield	N/A (N/A)
Ex-Dividend Date	N/A
1y Target Est	30.67

Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.

Fair Value

XX.XX

Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for ATNM

View details

Research that delivers an independent perspective, consistent methodology and actionable insight

Related Research

Actinium Pharmaceuticals, Inc.
Analyst Report: Pfizer Inc.Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding COVID-19 vaccine sales). While it historically sold many types of healthcare products and chemicals, now, prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, cardiovascular treatment Eliquis, and immunology drug Xeljanz. Pfizer sells these products globally, with international sales representing close to 50% of its total sales. Within international sales, emerging markets are a major contributor.
Rating
Fair Value
Economic Moat
3 days agoMorningstar

All

Zacks
Organogenesis (ORGO) Tops Q2 Earnings and Revenue Estimates
Organogenesis (ORGO) delivered earnings and revenue surprises of 12.50% and 0.33%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
- Avanos (AVNS) Q2 Earnings Top Estimates, FY22 View Lowered
  Zacks
- Similarweb (SMWB) Reports Q2 Loss, Tops Revenue Estimates
  Zacks
Zacks
Aurinia Pharmaceuticals (AUPH) Reports Q2 Loss, Tops Revenue Estimates
Aurinia (AUPH) delivered earnings and revenue surprises of -13.64% and 4.14%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Has Alkermes (ALKS) Outpaced Other Medical Stocks This Year?
Here is how Alkermes (ALKS) and Actinium Pharmaceuticals (ATNM) have performed compared to their sector so far this year.